http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30421754
Outgoing Links
Predicate | Object |
---|---|
contentType | Journal Article |
endingPage | 7 |
issn | 1948-5875 |
issueIdentifier | 1 |
pageRange | 6-7 |
publicationName | ACS Medicinal Chemistry Letters |
startingPage | 6 |
bibliographicCitation | Blass BE. Bridged Piperidine Derivatives Useful as γ-Secretase Inhibitors for the Treatment of Alzheimer’s Disease. ACS Med. Chem. Lett. 2018 Dec 07;10(1):6–7. doi: 10.1021/acsmedchemlett.8b00544. |
creator | http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2449-4503 |
date | 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier | https://pubmed.ncbi.nlm.nih.gov/PMC6331151 https://doi.org/10.1021/acsmedchemlett.8b00544 https://pubmed.ncbi.nlm.nih.gov/30655935 |
isPartOf | https://portal.issn.org/resource/ISSN/1948-5875 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 |
language | English |
source | https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title | Bridged Piperidine Derivatives Useful as γ-Secretase Inhibitors for the Treatment of Alzheimer’s Disease |
Incoming Links
Total number of triples: 33.